Connect with others who understand.

sign up log in
About MyDepressionTeam

What Are Schizophrenia and Schizoaffective Disorder?

Posted on November 18, 2021
Medically reviewed by
Paul Ballas, D.O.
Article written by
Brooke Dulka, Ph.D.

  • Schizophrenia is a psychotic disorder marked by hallucinations, delusions, and cognitive changes.
  • Schizoaffective disorder is a psychotic disorder with features of schizophrenia and mood disorders (such as depression) at the same time.
  • Although there is currently no cure for schizophrenia or schizoaffective disorder, symptoms can be managed using prescription drugs and psychotherapy.

Schizophrenia and schizoaffective disorder are serious mental health conditions and psychotic disorders. Both disorders are characterized by hallucinations, delusions, and cognitive disturbances. Although schizoaffective disorder does fall along the schizophrenia spectrum, it is now considered a distinct condition.

Schizophrenia and schizoaffective disorder are potentially debilitating to those who live with them. Knowing the difference between schizophrenia and schizoaffective disorder and how they relate to depression can help you understand the diagnosis and treatment options.

What Is Schizophrenia?

Schizophrenia is a serious mental health condition and psychotic disorder. According to a 2016 study across 195 countries and territories, this condition affects approximately 0.28 percent of the population across the world.

Risk Factors for Schizophrenia

There are several risk factors for developing schizophrenia. Some of these risk factors are environmental while others are genetic. The environmental risk factors for schizophrenia include infections, substance use, stress, and complications during pregnancy and birth.

Infectious Diseases

Research suggests that infections while in utero and during childhood and adolescence may lead to the later development of schizophrenia. This link may be related to inflammation in the brain caused by infections during these critical periods of development.

Complications During Pregnancy and Delivery

Besides infections, other complications of pregnancy have also been linked to schizophrenia. For instance, a child has a greater risk of later developing schizophrenia if they had a low birth weight or experienced malnutrition in utero. Some cardiovascular congenital anomalies are also associated with the development of schizophrenia.

Substance Use

Cannabis (marijuana) use has been linked to schizophrenia. In one study, when people self-reported the frequency of their cannabis use, as the number of times cannabis was used over a lifetime increased so did the odds of being diagnosed with schizophrenia. It is thought that cannabis use alone doesn’t cause schizophrenia, but it could reduce the time to disease onset in those predisposed to schizophrenia. This effect is likely due to the actions of tetrahydrocannabinol (THC), which is the component of the cannabis plant that causes a “high,” and not cannabidiol (CBD).

Stress

Research also suggests that stress during developmentally critical periods, such as adolescence, increases vulnerability to schizophrenia.

Seasonal Births

Studies have linked being born during winter and early spring (between January and May for those in the Northern Hemisphere) to the development of schizophrenia later in life. This may, in part, be due to factors such as temperature, humidity, daylight duration, infections, changes of maternal hormones, and other things a baby faces while in the womb.

Genetics of Schizophrenia

Schizophrenia is also strongly driven by genetics, as studies of families and twins have shown. Not only does schizophrenia run in families, but twin studies provide particularly compelling information about genetics by comparing the schizophrenia rates in twins who are identical (monozygotic) against twins who are not identical (dizygotic). Research shows that the likelihood of both monozygotic twins developing schizophrenia is 33 percent, while in dizygotic twins this rate is only 7 percent. From this data, researchers can conclude that genes are a strong (but not total) influence in the development of schizophrenia. Several genes have now been linked in scientific research to schizophrenia.

Symptoms of Schizophrenia

People tend to most closely associate schizophrenia with hallucinations, but the symptoms can be much more complicated than that. The symptoms of schizophrenia can be classified into three broad categories:

  • Positive symptoms
  • Negative symptoms
  • Cognitive symptoms

Positive Symptoms

Positive symptoms, which are also called psychotic symptoms, usually involve an altered sense of reality or the addition of something that is not actually there. Examples of positive symptoms of schizophrenia include hallucinations (visual or auditory), delusions (typically in relation to feeling important or persecuted), and thought disorder (which includes disorganized thinking or speaking).

Negative Symptoms

Negative symptoms happen when something that is normally present is lacking. For instance, a person with schizophrenia might have a lack of motivation, feel less pleasure in everyday life, be unable to express emotions as vividly (also called “flat affect”), and simply talk less than usual.

Cognitive Symptoms

Cognitive symptoms might affect a person’s ability to remember, process information, or focus on something. The degree to which cognitive symptoms affect someone with schizophrenia can vary greatly from person to person.

Diagnosing Schizophrenia

Schizophrenia is usually diagnosed by a psychiatrist or clinical psychologist after a thorough review of an individual's personal history, including an analysis of the symptoms the individual is currently experiencing. Physical tests may also be done to rule out other diseases.

Schizophrenia is typically diagnosed during early adulthood (most commonly in the late teens to early 20s for men and the late 20s to early 30s for women). This is when symptoms, such as psychosis, begin to manifest.

It can be hard to diagnose schizophrenia because psychosis can also occur in the context of depression and bipolar disorder. The use of amphetamines and hallucinogenic drugs can also cause symptoms similar to those seen in schizophrenia.

Treatment and Prognosis for Schizophrenia

Treatment for schizophrenia is lifelong, and there currently is no cure for this disorder. However, symptoms can be managed through the use of medications and different forms of therapy.

The main drugs used to treat schizophrenia are a class of pharmaceuticals called antipsychotics. Antipsychotics are typically an oral medication, although sometimes long-lasting antipsychotic injections can be administered. Common antipsychotics used today include:

  • Abilify (aripiprazole)
  • Clozaril (clozapine)
  • Geodon (ziprasidone)
  • Invega (paliperidone)
  • Latuda (lurasidone)
  • Risperdal (risperidone)
  • Seroquel (quetiapine)
  • Versacloz (clozapine)
  • Zyprexa (olanzapine)

While medications are usually the first-line treatment against symptoms of schizophrenia, psychotherapy or talk therapy can also help. Research has shown that a form of psychotherapy known as cognitive behavioral therapy (CBT) can help individuals with schizophrenia better manage their symptoms. CBT is a form of psychotherapy that focuses on being aware of, and changing, thought and behavior patterns. Often, CBT teaches specific skills and techniques, such as acceptance or problem-solving.

What Is Schizoaffective Disorder?

Schizoaffective disorder is a condition on the schizophrenia spectrum. This disorder is partially a psychotic disorder and partially a mood disorder. That is, schizoaffective disorder has components of schizophrenia along with components of a mood disorder (either depression or bipolar disorder). There are two types of schizoaffective disorder: the bipolar type and the depressive type. Schizoaffective disorder can present itself uniquely in each person though.

In one epidemiological study conducted in Finland, schizoaffective disorder was found to affect approximately 0.32 percent of the general population. (It is worth noting that this study also found schizophrenia rates of 0.87 percent.) This data suggests that schizoaffective disorder may be even more rare than schizophrenia.

Risk Factors for Schizoaffective Disorder

One risk factor for schizoaffective disorder is having a family member with either schizoaffective disorder, schizophrenia, or bipolar disorder. Thus, genetics likely play a role. Other risk factors include stress and substance use. For instance, some studies have shown that cannabis use can negatively impact remission rates in those with the bipolar type of schizoaffective disorder. Schizoaffective disorder is not unlike schizophrenia in that way. However, schizophrenia has been studied somewhat more than schizoaffective disorder.

Symptoms of Schizoaffective Disorder

People with schizoaffective disorder can display all of the symptoms associated with schizophrenia. This includes psychotic or positive symptoms (hallucinations or delusions), negative symptoms such as lack of motivation or flat affect, and cognitive symptoms like confusion.

There are two types of schizoaffective disorder, each with slightly different symptoms: the bipolar type and the depressive type.

Bipolar Type Schizoaffective Disorder

In the bipolar type of schizoaffective disorder, symptoms are a mix of schizophrenia symptoms and bipolar disorder symptoms. Bipolar disorder is a mood disorder characterized by alternating periods of the “highs” of mania and the “lows” of depression. The bipolar-like symptoms associated with schizoaffective disorder fall under two categories:

  • Mania — This includes periods of elevated moods, increased energy, talkativeness, and feeling excited. Mania also involves acting out of control, experiencing racing thoughts, and making impulsive or risky decisions.
  • Depression — This includes periods of depressed mood, sadness, and decreased energy. Feeling suicidal or engaging in self-injury behavior can also be characteristic of depression.

Depressive Type Schizoaffective Disorder

In the depressive type of schizoaffective disorder, symptoms lean toward depression. The most common symptoms of a depressive episode associated with schizoaffective disorder are feeling sad or inadequate, experiencing decreased energy, having changes in appetite, and finding little joy in activities once held dear. Symptoms may also include feeling suicidal or engaging in self-harm behaviors.

Diagnosing Schizoaffective Disorder

Due to the similarities that schizoaffective disorder shares with both schizophrenia and mood disorders, many people with schizoaffective disorder are incorrectly diagnosed initially. Some scientists believe schizoaffective disorder is not a unique disorder, but rather represents a comorbid (or concurrent) mood disorder and schizophrenia. Like other psychiatric conditions, schizoaffective disorder is best diagnosed by a psychiatrist or psychologist through an extensive clinical interview.

Treatment and Prognosis for Schizoaffective Disorder

Like schizophrenia, schizoaffective disorder is not yet curable, but it is manageable. It is a lifelong condition that requires medication — and typically psychotherapy, such as CBT. Because of the extensive mood symptoms that occur as a part of schizoaffective disorder, treatment can be complicated. Medications used (in some combination) to treat schizoaffective disorder include antipsychotics, antidepressants, and mood stabilizers.

Antipsychotics

Antipsychotics are primarily used to treat the schizophrenia-like symptoms of schizoaffective disorder. These drugs can include Risperdal (risperidone), Abilify (aripiprazole), and Latuda (lurasidone).

Antidepressants

Antidepressants help some people manage their depressive symptoms. Examples of antidepressants include selective serotonin reuptake inhibitors (SSRIs), such as Prozac (fluoxetine).

Mood Stabilizers

Mood stabilizers are drugs that are also used to treat seizures. At the right doses, they can also be used for bipolar-type schizoaffective disorder to stabilize mood swings. Some of these drugs include Lamictal (lamotrigine), Depakote (divalproex sodium), and lithium.

What’s the Connection With Depression?

The connection between schizophrenia, schizoaffective disorder, and depression can be complicated. Depression is often a symptom of schizoaffective disorder. However, people with schizophrenia can also experience symptoms of depression. In one study of 90 individuals with stable schizophrenia or schizoaffective disorder, 31 percent were found to have clinically relevant symptoms of depression.

Having multiple conditions can complicate treatment. Research shows that having comorbid schizophrenia spectrum disorders and depression decreases the quality of life of individuals living with these conditions.

If you have been diagnosed with depression, schizophrenia, or schizoaffective disorder, it is important to stay aware of your thoughts, feelings, and mood. Be open and honest with your doctor and therapists about your experience, so they can help you manage your symptoms.

Be particularly vigilant about the increased risk for suicidal behaviors among people with schizophrenia. Reach out to your doctor or health care team immediately if you have any thoughts of self-harm.

Talk With Others Who Understand

MyDepressionTeam is the social network for people with depression and their loved ones. On MyDepressionTeam, more than 138,000 members come together to ask questions, give advice, and share their stories with others who understand life with depression, schizophrenia, and schizoaffective disorder.

Do you live with schizophrenia or schizoaffective disorder? Share your experience in the comments below, or start a conversation by posting on your Activities page.

References
  1. Schizophrenia — National Institute of Mental Health
  2. Schizoaffective Disorder — National Alliance on Mental Illness
  3. Schizophrenia Spectrum Disorders — Noba Textbook Series: Psychology
  4. Quality of Life For Persons Living With Schizophrenia: More Than Just Symptoms — Psychiatric Rehabilitation Journal
  5. Global Epidemiology and Burden of Schizophrenia: Findings From the Global Burden of Disease Study 2016 — Schizophrenia Bulletin
  6. Epidemiology and Risk Factors of Schizophrenia — Neuroendocrinology Letters
  7. What Causes Seasonality of Birth in Schizophrenia? — Neuroscience Research
  8. Risk Factors in Schizophrenia: Season of Birth, Gender, and Familial Risk — The British Journal of Psychiatry
  9. Are Common Childhood or Adolescent Infections Risk Factors for Schizophrenia and Other Psychotic Disorders? — Medical Journal of Australia
  10. Pregnancy, Delivery, and Neonatal Complications in a Population Cohort of Women With Schizophrenia and Major Affective Disorders — The American Journal of Psychiatry
  11. Self Reported Cannabis Use as a Risk Factor for Schizophrenia in Swedish Conscripts of 1969: Historical Cohort Study — British Medical Journal
  12. Effects of Cannabis Use on Age at Onset in Schizophrenia and Bipolar Disorder — Schizophrenia Research
  13. Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial — The American Journal of Psychiatry
  14. Stress During Critical Periods of Development and Risk for Schizophrenia — Schizophrenia Research
  15. Initial Heritability Analyses of Endophenotypic Measures for Schizophrenia: The Consortium on the Genetics of Schizophrenia — JAMA Psychiatry
  16. Heritability of Schizophrenia and Schizophrenia Spectrum Based on the Nationwide Danish Twin Register — Biological Psychiatry
  17. Schizophrenia Genes, Gene Expression, and Neuropathology: On the Matter of Their Convergence — Molecular Psychiatry
  18. Schizophrenia — Mayo Clinic
  19. Schizophrenia — National Alliance on Mental Illness
  20. Cognitive-Behavioral Therapy for Schizophrenia: A Review — Focus
  21. What Is Cognitive Behavioral Therapy? — American Psychological Association
  22. Lifetime Prevalence of Psychotic and Bipolar I Disorders in a General Population — Archives of General Psychiatry
  23. The Genomics of Major Psychiatric Disorders in a Large Pedigree From Northern Sweden — Translational Psychiatry
  24. Impact of Cannabis Use on Long-Term Remission in Bipolar I and Schizoaffective Disorder — Psychiatry Investigation
  25. Schizoaffective Disorder: Diagnostic Issues and Future Recommendations — Bipolar Disorders
  26. Schizoaffective Disorder — Mayo Clinic
  27. Prevalence of Depression and Its Relationship With Other Clinical Characteristics in a Sample of Patients With Stable Schizophrenia — Comprehensive Psychiatry
  28. Subjective Quality of Life in First Episode Schizophrenia Spectrum Disorders With Comorbid Depression — Psychiatry Research
  29. Symptoms, Subtype, and Suicidality in Patients With Schizophrenia Spectrum Disorders — American Journal of Psychiatry
  30. Could Stress Cause Psychosis in Individuals Vulnerable to Schizophrenia? — CNS Spectrums

A MyDepressionTeam Member said:

Having a good week looking foreward to Christmas and New yr😄😄😄😄

posted 7 days ago

hug

Paul Ballas, D.O. is an attending psychiatrist at Friends Hospital in Philadelphia, Pennsylvania. Review provided by VeriMed Healthcare Network. Learn more about him here.
Brooke Dulka, Ph.D. is a freelance writer at MyHealthTeams. Learn more about her here.

Recent articles

Symptoms of schizophrenia can overlap with symptoms of mood disorders, such as depression or...

Recognizing Schizophrenic Symptoms in People With Depression

Symptoms of schizophrenia can overlap with symptoms of mood disorders, such as depression or...
Schizophrenia and schizoaffective disorder currently cannot be cured, but they can be...

How Are Schizophrenia and Schizoaffective Disorder Treated?

Schizophrenia and schizoaffective disorder currently cannot be cured, but they can be...
If you’re living with depression, you’re already aware of the impact the condition can have on...

Depression Awareness: How To Get Involved

If you’re living with depression, you’re already aware of the impact the condition can have on...
If you’re living with depression, you may be wondering whether vitamin D can affect your mental...

Vitamin D and Depression: What’s the Link?

If you’re living with depression, you may be wondering whether vitamin D can affect your mental...
To determine how you can reduce your medical expenses, MyDepressionTeam sat down with Susan Null...

How To Reduce Medical Bills: Top Financial Expert Shares 10 Tips

To determine how you can reduce your medical expenses, MyDepressionTeam sat down with Susan Null...
Bipolar disorder is characterized by alternating periods of mania and depression. There are...

What Is Bipolar Disorder?

Bipolar disorder is characterized by alternating periods of mania and depression. There are...
Three types of bipolar disorder are currently recognized: bipolar type 1, bipolar type 2, and...

Types of Bipolar Disorder: Understanding the Difference

Three types of bipolar disorder are currently recognized: bipolar type 1, bipolar type 2, and...
Bipolar disorder is a chronic condition that requires long-term medication maintenance. Mood...

How Is Bipolar Disorder Treated?

Bipolar disorder is a chronic condition that requires long-term medication maintenance. Mood...
Living with depression can come with a variety of symptoms, and sometimes that includes...

Live Q&A: Shattering the Stigma Around Migraine With Dr. Starling

Living with depression can come with a variety of symptoms, and sometimes that includes...
Naomi Osaka is among the most recent celebrities to publicly discuss a diagnosis of depression....

What Naomi Osaka’s Conversation About Depression Does for the Rest of Us

Naomi Osaka is among the most recent celebrities to publicly discuss a diagnosis of depression....
MyDepressionTeam My depression Team

Two Ways to Get Started with MyDepressionTeam

Become a Member

Connect with others who are living with depression. Get members only access to emotional support, advice, treatment insights, and more.

sign up

Become a Subscriber

Get the latest articles about depression sent to your inbox.

Not now, thanks

Privacy policy
MyDepressionTeam My depression Team

Thank you for signing up.

close